Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Virtual reality opens doors for older people to build closer connections in real life - 2Where America’s CO2 emissions come from – what you need to know, in charts
- 3NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
- 4Startled Venezuelans express relief but also fear after Maduro arrest
- 5Weather forecast, Turkana style: A goat's intestines tell it all
- Italy fertility rate fell to new low of 1.14 in 2025
- Vote In favor of Your Favored Web-based Visual depiction Administration
- New Jordan security fence could be done in early 2028
- Instructions to Guarantee Kids Foster Solid Dental Propensities
- Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- Historical mysteries solved by science in 2025
- Figure out How to Augment the Advantages of a Web-based Degree
